Sort
23,748 grants matching “melanoma”
Hereditary cancer predisposition syndromes and uveal melanoma
$200,970Mohamed H. Abdel-Rahman · Ohio State University · R21 · FY2015 · CA
Targeting melanoma hypoxia with lactic acid bacterium L. lactis
$200,970Jorge G Gomez-Gutierrez · University Of Louisville · R21 · FY2017 · CA
Common hTERT Promoter Mutations Represent a Novel Therapeutic Target
$200,970Donald M Miller · University Of Louisville · R21 · FY2017 · CA
Post-transplant Cutaneous Squamous Cell Carcinoma and Macrophage Migration Inhibitory Factor
$200,970Tatiana M Oberyszyn · Ohio State University · R21 · FY2016 · CA
IL-27-based cancer vaccination approach for cancer immunotherapy
$200,970Xue-Feng Bai · Ohio State University · R21 · FY2016 · CA
Exploring IL-36gamma as a new tumor immune therapy
$200,970Binfeng Lu · University Of Pittsburgh At Pittsburgh · R21 · FY2016 · CA
Examining role of splicing factor mutations in myelodysplastic syndrome (PQ11)
$200,970Shalini Sharma · University Of California Los Angeles · R21 · FY2012 · CA
Molecular Targeting of Lymphatic Endothelial Receptors for Ligand-directed Imagin
$200,968Renata Pasqualini · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Fullerene Immunoconjugates for Cancer Imaging and Treatment
$200,937Robert D Bolskar · Tda Research, Inc. · R43 · FY2007 · CA
Exosome Secretion in Tumor Aggressiveness
$200,877Bong Hwan Sung · Vanderbilt University · R50 · FY2024 · CA
Exosome Secretion in Tumor Aggressiveness
$200,877Bong Hwan Sung · Vanderbilt University · R50 · FY2025 · CA
Sun Safety Ink A Skin Cancer Prevention Program for the Tattoo Community
$200,818Barbara Walkosz · Klein Buendel, Inc. · R21 · FY2013 · CA
NM23 PROTEINS AND MECHANISMS OF PDGF A CHAIN SILENCING
$200,789University Of Kentucky · R01 · FY2000 · CA
Listeria-Based Therapeutic Cancer Vaccine for Melanoma
$200,763Dirk G. Brockstedt · Aduro Biotech · R43 · FY2010 · CA
Adhesion GPCR interactome landscaping by in vivo biotinylation proteomics
$200,729Xianhua Piao · University Of California, San Francisco · R21 · FY2019 · NS
Moving TIL Therapy Past the Valley of Death
$200,624John Wilson · Wilson Wolf Manufacturing Corporation · U44 · FY2014 · CA
TREATMENT AND MOLECULAR ANALYSIS OF ATYPICAL NEVI
$200,622University Of Pittsburgh At Pittsburgh · R01 · FY2002 · CA
PIGMENTARY MODEL FOR THYROID HORMONE ACTIONS ON STEM CELL LINEAGES
$200,574David M Parichy · University Of Washington · R01 · FY2016 · GM
A zebrafish model for studying orbital development and disease
$200,534Alon Kahana · University Of Michigan At Ann Arbor · K08 · FY2009 · EY
HUMAN IMMUNOLOGIC MONITORING AND CGMP
$200,518Michelle M Le Beau · University Of Chicago · P30 · FY2014 · CA
DELINEATING GERMLINE, TUMOR AND EXTRINSIC FACTORS DRIVING MUCOSAL MELANOMA RISK AND RESPONSE
$200,510The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Department of the Army
Targeting Smad3-Ski for Therapeutic Development in Pancreatic Cancer
$200,475F. Michael Hoffmann · University Of Wisconsin-Madison · R21 · FY2009 · CA
Pilot Study of a Spiritually-Focused Intervention
$200,475University Of Pittsburgh At Pittsburgh · R21 · FY2004 · CA
Etheno Adducts in Liver Cancer
$200,425Gerd P Pfeifer · Van Andel Research Institute · R21 · FY2019 · CA
Defining an immunological mechanism for a microbiota-based therapy for colorectal cancer
$200,410Timothy Wesley Hand · University Of Pittsburgh At Pittsburgh · R21 · FY2021 · CA